免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料，僅供一般參考，不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

CitriCon 液體和粉末（使用檸檬酸酸化的酸濃縮液），AcetiCon 液體和粉末（使用醋酸或醋酸鈉酸化的酸濃縮液），BicarboCon 液體和粉末（重碳濃縮液），RenaCon 液體和粉末（含有醋酸鈉的醋酸濃縮液）

K 號：K180679 · 2018-12-07

申請人Global Scientific Technologies, LLC
決定日期2018-12-07
產品代碼KPO
諮詢委員會GU
決定相當於

器材摘要

CitriCon Liquid and Powder (Acid Concentrate acidified with Citric Acid), AcetiCon Liquid and Powder (Acid Concentrate acidified with Acetic Acid or Na Di Acetate), BicarboCon Liquid and Powder (Bicarb Concentrate), RenaCon Liquid and Powder (Acetate Concentrate with Na Acetate) is the device name listed in this FDA 510(k) record. The listed applicant is Global Scientific Technologies, LLC. It received FDA 510(k) clearance on 2018-12-07 under 510(k) number K180679. The device is classified under product code KPO. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the CitriCon Liquid and Powder (Acid Concentrate acidified with Citric Acid), AcetiCon Liquid and Powder (Acid Concentrate acidified with Acetic Acid or Na Di Acetate), BicarboCon Liquid and Powder (Bicarb Concentrate), RenaCon Liquid and Powder (Acetate Concentrate with Na Acetate)?

CitriCon Liquid and Powder (Acid Concentrate acidified with Citric Acid), AcetiCon Liquid and Powder (Acid Concentrate acidified with Acetic Acid or Na Di Acetate), BicarboCon Liquid and Powder (Bicarb Concentrate), RenaCon Liquid and Powder (Acetate Concentrate with Na Acetate) is a medical device that received FDA 510(k) clearance on 2018-12-07. The listed applicant is Global Scientific Technologies, LLC. The 510(k) number is K180679.

When did CitriCon Liquid and Powder (Acid Concentrate acidified with Citric Acid), AcetiCon Liquid and Powder (Acid Concentrate acidified with Acetic Acid or Na Di Acetate), BicarboCon Liquid and Powder (Bicarb Concentrate), RenaCon Liquid and Powder (Acetate Concentrate with Na Acetate) receive FDA 510(k) clearance?

CitriCon Liquid and Powder (Acid Concentrate acidified with Citric Acid), AcetiCon Liquid and Powder (Acid Concentrate acidified with Acetic Acid or Na Di Acetate), BicarboCon Liquid and Powder (Bicarb Concentrate), RenaCon Liquid and Powder (Acetate Concentrate with Na Acetate) received FDA 510(k) clearance on 2018-12-07, under 510(k) number K180679.

Who is the listed applicant for CitriCon Liquid and Powder (Acid Concentrate acidified with Citric Acid), AcetiCon Liquid and Powder (Acid Concentrate acidified with Acetic Acid or Na Di Acetate), BicarboCon Liquid and Powder (Bicarb Concentrate), RenaCon Liquid and Powder (Acetate Concentrate with Na Acetate)?

The FDA 510(k) record lists Global Scientific Technologies, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CitriCon Liquid and Powder (Acid Concentrate acidified with Citric Acid), AcetiCon Liquid and Powder (Acid Concentrate acidified with Acetic Acid or Na Di Acetate), BicarboCon Liquid and Powder (Bicarb Concentrate), RenaCon Liquid and Powder (Acetate Concentrate with Na Acetate)?

The FDA product code for CitriCon Liquid and Powder (Acid Concentrate acidified with Citric Acid), AcetiCon Liquid and Powder (Acid Concentrate acidified with Acetic Acid or Na Di Acetate), BicarboCon Liquid and Powder (Bicarb Concentrate), RenaCon Liquid and Powder (Acetate Concentrate with Na Acetate) is KPO.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

NCT07608549FLASH 預試階段 1 安全性研究NOT_YET_RECRUITINGNCT06562205PAP系統外部臨床研究（ECS）NOT_YET_RECRUITINGNCT06443177對於動脈瘤性硬腦膜下出血引起的腦血管收縮，交感調節的影響SUSPENDEDNCT07095751人工智能協助的Uro-Cam導尿管評估系統，用於診斷膀胱癌NOT_YET_RECRUITING

相關器械（代碼：KPO）

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K260799尼普羅乾性酸濃縮混合器Nipro Technical Solutions, IncoporatedK253462NaturaLyte®乾性重碳濃縮液（08-4112-2）Fresenius Medical Care Renal Therapies Group, LLCK252180Bicarby Dialysate RFP-404 (RFP-404-W)；Bicarby Dialysate RFP-403 (RFP-403-W)；Bicarby Dialysate RFP-403 (RFP-403-G)；Bicarby Dialysate RFP-453 (RFP-453-W)；Bicarby Dialysate RFP-453 (RFP-453-G)；Bicarby Dialysate RFP-454 (RFP-454-W)；Bicarby Dialysate RFP-454 (RFP-454-G)；Bicarby Dialysate RFP-456 (RFP-456-W)Fresenius Medical Care Renal Therapies Group, LLCK243786雙碳比透析液 RFP-402 (RFP-402-G)；雙碳比透析液 RFP-400 (RFP-400-G)；雙碳比透析液 RFP-407 (RFP-407-G)；雙碳比透析液 RFP-401 (RFP-401-G)；雙碳比透析液 RFP-404 (RFP-404-G)；雙碳比透析液 RFP-456 (RFP-456-G)；鋅鐵離子透析液 2K (RFP-457-G)；鋅鐵離子透析液 4K (RFP-458-G)Fresenius Medical Care Renal Therapies Group, LLCK240920HemoCare Bicarbonate Concentrate Set (BCS)Deka Research and DevelopmentK233950pureFLOW 402 (F00012067)；pureFLOW 406 (F00012068)；pureFLOW 401 (F00012069)；pureFLOW 400 (F00012070)Fresenius Medical Care Renal Therapies Group, LLC

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。

↑